Zhang et al. identified GRIM-19 (gene associated with retinoid-IFN-induced mortality-19) as a specific STAT3 binding partner in different breast cancer cell lines (i.e., MCF-7, T47D, and BT20) [72]. This evidence concerns the gene STAT3 and breast carcinoma.